Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI).
A combined medication, Symbyax, developed by Eli Lilly and Company, comprises olanzapine (Zyprexa) and fluoxetine (Prozac). Olanzapine is an atypical antipsychotic, while fluoxetine is a selective serotonin reuptake inhibitor.